Abstract | BACKGROUND: METHODS: The experimental group (LC) consisted of 13 liver cirrhosis patients. A second experimental group (PT) included 24 patients, post- liver transplantation, receiving immunosuppressive therapy. Seventeen healthy subjects formed a control group. The Ramfjord index teeth were recorded for plaque index (PI), gingival index (GI), probing depth (PD), clinical attachment level (CAL), and gingival overgrowth (GO). RESULTS: Mean PI and mean GI for the LC, PT, and C groups were not statistically different (P >0.05). Mean PD for the LC (3.32+/-0.24 mm) and PT group (3.41+/-0.13 mm) was significantly higher (P = 0.0001, ANOVA) compared to the C group (2.45+/-0.16 mm). Likewise, CAL for the LC (4.89+/-0.47 mm) and PT group (4.68+/-0.47 mm) was significantly higher (P = 0.001, ANOVA) than the C group (2.78+/-0.23 mm). Patients in the PT group exhibited the greatest mean GO scores (0.88+/-0.09) compared to the LC group (0.37+/-0.07) and the C group (0.09+/-0.02). All 3 groups were significantly different from each other (P = 0.0001) despite great variability within the groups. GO in the CsA-treated patients (1.1+/-0.09) was significantly higher (P = 0.0001) than in those treated with tacrolimus (0.57+/-0.1). CONCLUSIONS:
Liver cirrhosis patients demonstrated greater pocketing and attachment loss compared to healthy matched controls. These same differences were observed in patients post- transplantation. Gingival overgrowth occurred as a result of the immunosuppressive therapy with CsA, while to a lesser degree with tacrolimus. Replacement of CsA by tacrolimus in patients manifesting gingival overgrowth might be recommended whenever possible to overcome this problem.
|
Authors | O Oettinger-Barak, S Barak, E E Machtei, L Ardekian, Y Baruch, M Peled |
Journal | Journal of periodontology
(J Periodontol)
Vol. 72
Issue 9
Pg. 1236-40
(Sep 2001)
ISSN: 0022-3492 [Print] United States |
PMID | 11577956
(Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
|
Chemical References |
- Immunosuppressive Agents
- Cyclosporine
- Tacrolimus
|
Topics |
- Analysis of Variance
- Cyclosporine
(adverse effects)
- Female
- Gingival Hyperplasia
(etiology)
- Humans
- Immunosuppressive Agents
(adverse effects)
- Liver Cirrhosis
(complications)
- Liver Transplantation
(adverse effects)
- Male
- Middle Aged
- Statistics, Nonparametric
- Tacrolimus
(adverse effects)
|